Compare · CELC vs UNH
CELC vs UNH
Side-by-side comparison of Celcuity Inc. (CELC) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CELC and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $362.78B, about 84.3x CELC ($4.31B).
- Over the past year, CELC is up 582.9% and UNH is up 31.9% - CELC leads by 551.1 points.
- CELC has been more active in the news (15 items in the past 4 weeks vs 7 for UNH).
- UNH has more recent analyst coverage (25 ratings vs 14 for CELC).
- Company
- Celcuity Inc.
- UnitedHealth Group Incorporated
- Price
- $88.20-4.55%
- $398.25+0.44%
- Market cap
- $4.31B
- $362.78B
- 1M return
- -36.77%
- +8.87%
- 1Y return
- +582.93%
- +31.86%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2017
- News (4w)
- 15
- 7
- Recent ratings
- 14
- 25
Celcuity Inc.
Celcuity Inc., a clinical stage biotechnology company, discovers cancer sub-types and therapeutic options for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest CELC
- SEC Form 424B5 filed by Celcuity Inc.
- SEC Form 305B2 filed by Celcuity Inc.
- Chief Science Officer Laing Lance G. exercised 1,000 shares at a strike of $9.89, increasing direct ownership by 0.08% to 1,251,000 units (SEC Form 4)
- SEC Form FWP filed by Celcuity Inc.
- Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
- Celcuity Inc. Announces Public Offering of Convertible Senior Notes Due 2032
- SEC Form 424B5 filed by Celcuity Inc.
- Celcuity's Gedatolisib Combination Regimens Doubled the Likelihood of Survival without Disease Progression or Death Compared to Alpelisib plus Fulvestrant in the PIK3CA Mutant Cohort of the Pivotal Phase 3 VIKTORIA-1 Trial in Patients with HR+/HER2- Advanced Breast Cancer
- Celcuity Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026
Latest UNH
- UnitedHealth Group Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- EVP & Chief Legal Officer Zaetta Christopher R covered exercise/tax liability with 134 shares, decreasing direct ownership by 0.80% to 16,582 units (SEC Form 4)
- Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 204 shares, decreasing direct ownership by 1% to 17,601 units (SEC Form 4)
- UnitedHealth upgraded by BofA Securities with a new price target
- UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
- UnitedHealthcare Eliminates Nearly Two-Thirds of Prior Authorization Requirements for Pediatric Care
- UnitedHealthcare Community Plan of D.C. Earns NCQA LTSS Distinction
- SEC Form DEFA14A filed by UnitedHealth Group Incorporated
- UnitedHealthcare Community Plan of Idaho Provides More Than $425,000 to Help Build Healthier Communities Statewide
- UnitedHealth Group Incorporated filed SEC Form 8-K: Regulation FD Disclosure